Synopsys Stock Sees Volatility After Q3 Earnings, Analysts See Buying Opportunity
ByAinvest
Friday, Sep 12, 2025 10:42 am ET1min read
SNPS--
Mizuho has adjusted its price target for Synopsys to $600, indicating substantial upside potential. The financial services firm maintained an "Outperform" rating despite the downward revision, reflecting continued confidence in Synopsys' potential market performance [2].
Valuation metrics for Synopsys show mixed signals. The company's P/E ratio of 34.38 is close to a 5-year low, suggesting undervaluation. However, the GF Value estimate of $579.13 indicates that the stock is "Modestly Undervalued" [2]. Despite this, concerns remain about Synopsys' financial health, as evidenced by a low Piotroski F-Score and Beneish M-Score.
Looking ahead, Synopsys projects next fiscal year revenues between $7.03 and $7.06 billion, highlighting the firm’s optimistic outlook on its growth trajectory [1]. Wall Street analysts present an encouraging perspective for Synopsys, with an average one-year price target of $584.53 and a consensus recommendation of "Outperform" [2].
Synopsys (SNPS) shares have rebounded 12.94% after a 36% plunge following Q3 2025 earnings disappointments. Mizuho has adjusted its price target to $600, indicating substantial upside potential. Valuation metrics show mixed signals, with a P/E ratio of 34.38 close to a 5-year low, and a GF Value estimate of $579.13 indicating the stock is "Modestly Undervalued." However, concerns remain about financial health, including a low Piotroski F-Score and Beneish M-Score.
Synopsys (SNPS) shares have rebounded 12.94% following a 36% plunge after the company's Q3 2025 earnings disappointed Wall Street. Despite the earnings miss, the company's revenue grew by 13.7% year-over-year to $1.74 billion, albeit slightly under expectations by $30 million [1].Mizuho has adjusted its price target for Synopsys to $600, indicating substantial upside potential. The financial services firm maintained an "Outperform" rating despite the downward revision, reflecting continued confidence in Synopsys' potential market performance [2].
Valuation metrics for Synopsys show mixed signals. The company's P/E ratio of 34.38 is close to a 5-year low, suggesting undervaluation. However, the GF Value estimate of $579.13 indicates that the stock is "Modestly Undervalued" [2]. Despite this, concerns remain about Synopsys' financial health, as evidenced by a low Piotroski F-Score and Beneish M-Score.
Looking ahead, Synopsys projects next fiscal year revenues between $7.03 and $7.06 billion, highlighting the firm’s optimistic outlook on its growth trajectory [1]. Wall Street analysts present an encouraging perspective for Synopsys, with an average one-year price target of $584.53 and a consensus recommendation of "Outperform" [2].

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet